| Bioactivity | Magnesium Lithospermate B, a derivative of caffeic acid tetramer, and is extracted from Salviae miltiorrhizae. Magnesium Lithospermate B is widely used for the research of cardiovascular diseases, and it can protect against glucose-induced intracellular oxidative damage. Magnesium Lithospermate B also suppresses neuroinflammation and attenuates neurodegeneration[1][2][3]. | ||||||||||||
| Invitro | Magnesium Lithospermate B (20-60 μg/ml; 24 h) decreases LDH activity in the cultured supernatant, increases SOD activity in cardiomyocytes, reduces intracellular ROS and MDA levels, and significantly suppresses cardiomyocytes apoptosis[2].Magnesium Lithospermate B (1-100 μg/ml) enhances proliferation of neural stem cells (NSCs) in a dose-dependent manner[3].Magnesium Lithospermate B (10 μg/ml) promotes the differentiation in vitro of NSCs towards neurons[3]. | ||||||||||||
| Name | Magnesium Lithospermate B | ||||||||||||
| CAS | 122021-74-3 | ||||||||||||
| Formula | C36H28MgO16 | ||||||||||||
| Molar Mass | 740.90 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Magnesium Lithospermate B
CAS: 122021-74-3 F: C36H28MgO16 W: 740.90
Magnesium Lithospermate B, a derivative of caffeic acid tetramer, and is extracted from Salviae miltiorrhizae. Magnesium
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.